Skip to main content
Clinical Trials/NCT06037785
NCT06037785RecruitingNot Applicable

Biobehavioral Intervention to Reduce PTSD After ICD Shock

University of Washington1 site in 1 country60 target enrollmentStarted: October 1, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
60
Locations
1
Primary Endpoint
ICD Shock anxiety

Study Overview

Brief Summary

This study, "Biobehavioral Intervention to Reduce PTSD Symptoms After an ICD Shock," addresses a critical need in cardiology care by describing the feasibility and acceptability of a timely, highly promising, electronically-delivered intervention for patients who have recently received an ICD delivered shock. The study intervention and outcomes are designed to reduce anxiety, enhance return to activities of daily living (ADLs), and prevent the development of severe distress and post-traumatic stress disorder (PTSD), and ultimately promote quality of life. The study is a two-arm, embedded mixed methods, randomized trial (N=60, 30/group). The purpose is to determine feasibility and potential effects of a self-management intervention (SPSM) plus usual care (UC) compared to UC alone, delivered during the critical 1 month period after an ICD shock when distress is high. The intervention will be delivered over 1 month following an ICD shock; a 6-month follow-up will be used to assess the sustainability of intervention effects and determine if the incidence of PTSD is reduced. SPSM includes: 1) training in heart rate (HR) self-monitoring; and 2) individualized learning through 4 self-paced, web-based modules. The study interventions are delivered at a crucial time, closely after an ICD shock when stress is high, but PTSD has not yet developed. The specific aims are to: 1) examine the effects of the SPSM intervention plus UC vs. UC alone on the primary outcome of ICD shock anxiety at 1 and 6 months post-shock event, 2) describe the impact of SPSM plus UC compared to UC alone on the secondary outcomes of total daily physical activity, depression, PTSD symptoms, QOL, salivary cortisol levels, and self-efficacy and outcome expectations at 1 and 6 months post-shock event, and 3) assess feasibility, acceptability, and safety of the SPSM intervention, SDOH will be used to describe differential responses to the SPSM intervention. This study fills a significant gap in the care of patients with an ICD, through the systematic testing of a brief, novel and cost-effective intervention that provides the knowledge and skills to improve quality of life. Study findings will be used to design future larger RCTs to test intervention effectiveness for more diverse samples and settings.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Care Provider, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •ICD implant for primary or secondary prevention of sudden cardiac arrest (SCA),
  • •receipt of at least 1 ICD shock, appropriate or inappropriate, one week prior to enrollment;
  • •able to read, speak and write English;
  • •access to online resources and telephone for study duration.

Exclusion Criteria

  • •current diagnosis of PTSD, schizophrenia or bipolar disorder;
  • •Short BLESSED score >6 indicating cognitive dysfunction [73];
  • •age <18 years;
  • •AUDIT-C score ≥4 for alcohol use;
  • •regular non-medical use of illicit drugs

Arms & Interventions

SPSM intervention

Experimental

Heart rate self monitoring Online shock management modules

Intervention: Self-Paced Self-Management (SPSM) (Behavioral)

usual care

No Intervention

standard observation and post-ICD shock care at each clinic that includes ICD interrogations monitored in-person or via home monitor

Outcomes

Primary Outcomes

ICD Shock anxiety

Time Frame: Baseline, 1, 6 months

Florida Shock Anxiety Scale: range 1-50, higher is higher anxiety.

Secondary Outcomes

  • Total daily physical activity(steps/day)(Baseline, 1, 6 months)
  • Depression(Baseline, 1, 6 months)
  • PTSD Symptoms(Baseline, 1, 6 months)
  • Quality of Life-Physical and Mental(Baseline, 1, 6 months)
  • Self-Efficacy Expectations(Baseline, 1, 6 months)
  • Outcome expectation, 0-90. Higher is higher OE.(Baseline, 1, 6 months)
  • Salivary cortisol(Baseline, 1, 6 months)
  • Acceptability(6 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Cynthia M. Dougherty

Professor, School of Nursing

University of Washington

Study Sites (1)

Loading locations...

Similar Trials